Cargando…
Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular preventio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041885/ https://www.ncbi.nlm.nih.gov/pubmed/33846483 http://dx.doi.org/10.1038/s41598-021-87075-4 |
_version_ | 1783678031107194880 |
---|---|
author | Lazzeroni, Davide Moderato, Luca Marazzi, P. L. Pellegrino, Carmen Musiari, Elisa Castiglioni, Paolo Camaiora, Umberto Bini, Matteo Geroldi, Simone Brambilla, Lorenzo Brambilla, Valerio Coruzzi, Paolo |
author_facet | Lazzeroni, Davide Moderato, Luca Marazzi, P. L. Pellegrino, Carmen Musiari, Elisa Castiglioni, Paolo Camaiora, Umberto Bini, Matteo Geroldi, Simone Brambilla, Lorenzo Brambilla, Valerio Coruzzi, Paolo |
author_sort | Lazzeroni, Davide |
collection | PubMed |
description | The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan–Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan–Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19–1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23–1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01–1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01–1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation. |
format | Online Article Text |
id | pubmed-8041885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80418852021-04-13 Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery Lazzeroni, Davide Moderato, Luca Marazzi, P. L. Pellegrino, Carmen Musiari, Elisa Castiglioni, Paolo Camaiora, Umberto Bini, Matteo Geroldi, Simone Brambilla, Lorenzo Brambilla, Valerio Coruzzi, Paolo Sci Rep Article The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan–Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan–Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19–1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23–1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01–1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01–1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation. Nature Publishing Group UK 2021-04-12 /pmc/articles/PMC8041885/ /pubmed/33846483 http://dx.doi.org/10.1038/s41598-021-87075-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lazzeroni, Davide Moderato, Luca Marazzi, P. L. Pellegrino, Carmen Musiari, Elisa Castiglioni, Paolo Camaiora, Umberto Bini, Matteo Geroldi, Simone Brambilla, Lorenzo Brambilla, Valerio Coruzzi, Paolo Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
title | Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
title_full | Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
title_fullStr | Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
title_full_unstemmed | Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
title_short | Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
title_sort | red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041885/ https://www.ncbi.nlm.nih.gov/pubmed/33846483 http://dx.doi.org/10.1038/s41598-021-87075-4 |
work_keys_str_mv | AT lazzeronidavide redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT moderatoluca redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT marazzipl redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT pellegrinocarmen redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT musiarielisa redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT castiglionipaolo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT camaioraumberto redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT binimatteo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT geroldisimone redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT brambillalorenzo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT brambillavalerio redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery AT coruzzipaolo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery |